Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06788717 · ClinicalTrials.gov registry record

MDR - Comprehensive Primary Revision Stems PMCF

A clinical trial of Shoulder Pain and Shoulder Injuries, sponsored by Zimmer Biomet.

Recruiting
Registry status
59
Enrollment target
2
Study locations

NCT06788717: Recruiting study of Shoulder Pain and Shoulder Injuries, sponsored by Zimmer Biomet.

NCT06788717 is a study of Shoulder Pain and Shoulder Injuries that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 59 participants, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06788717, a study of Shoulder Pain and Shoulder Injuries, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
59 participants
Enrollment target
2
Study locations

Study Summary

The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthroplasty at 1, 3, 5, 7 and 10 years.

Interventions

  • DEVICE Comprehensive Primary Revision Stems

Study Locations (2)

California

  • Cedars Sinai Medical Center - Los Angeles

Other

  • Aalborg University Hospital - Aalborg

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2025-06-19
Est. Completion 2040-12
Zimmer Biomet

115 total trials

What NCT06788717 shows while recruiting

NCT06788717 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 99-participant average among 27 other Shoulder Pain trials with a reported enrollment target (40% lower).

The record links to 5 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Primary Revision Stems is the first listed.

NCT06788717 reports a single indexed study location in California, Other.

Frequently Asked Questions

What is clinical trial NCT06788717 about?

NCT06788717 is a clinical study titled "MDR - Comprehensive Primary Revision Stems PMCF". The objective of this retrospective and prospective consecutive series PMCF (Post Market Clinical Follow Up) study is to collect long-term data confirming safety, performance and clinical benefits of the Comprehensive Primary Revision Stems (implants and instrumentation) when used for shoulder arthr...

What is the current status of trial NCT06788717?

This trial is currently recruiting. The enrollment target is 59 participants. The study started on 2025-06-19. Estimated completion is 2040-12.

What conditions does trial NCT06788717 study?

This clinical trial studies the following conditions: Shoulder Pain, Shoulder Injuries, Shoulder Arthritis, Shoulder Disease, Shoulder Fractures.

What interventions are being tested in trial NCT06788717?

The interventions under investigation include: Comprehensive Primary Revision Stems (DEVICE).

Who is sponsoring clinical trial NCT06788717?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06788717 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06788717's enrollment target sits among peer trials

59 15th of 27 higher than 13 of 27 other Shoulder Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03801083 · 59 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

  • NCT04332367 · 59 participants · Phase 2

    Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance

  • NCT05489575 · 59 participants · NA

    CPAP for the Treatment of Supine Hypertension

  • NCT06721689 · 59 participants · Phase 1

    PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06788717, the US trial registry maintained by the National Library of Medicine. NCT06788717 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.